Congress has promised to raise more money to enable the FDA to inspect foreign drug-making plants more frequently, but has yet to decide upon a method for that fundraising.
A series of recent recalls of products made in China, including pet food and toothpaste, has drawn attention to the risks posed by an increasingly globalized world market.
